BioMarin Pharmaceutical, Inc. (BMRN)
58.37
+0.88
(+1.53%)
USD |
NASDAQ |
Oct 30, 10:18
BioMarin Pharmaceutical Cash and Short Term Investments (Annual) : 1.561B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.561B |
| December 31, 2024 | 1.138B |
| December 31, 2023 | 1.074B |
| December 31, 2022 | 1.292B |
| December 31, 2021 | 1.014B |
| December 31, 2020 | 1.065B |
| December 31, 2019 | 753.81M |
| December 31, 2018 | 1.084B |
| December 31, 2017 | 1.396B |
| December 31, 2016 | 789.68M |
| December 31, 2015 | 599.97M |
| December 31, 2014 | 945.19M |
| December 31, 2013 | 784.72M |
| December 31, 2012 | 450.74M |
| December 31, 2011 | 195.09M |
| Date | Value |
|---|---|
| December 31, 2010 | 274.11M |
| December 31, 2009 | 300.68M |
| December 31, 2008 | 565.99M |
| December 31, 2007 | 585.59M |
| December 31, 2006 | 288.85M |
| December 31, 2005 | 47.79M |
| December 31, 2004 | 74.11M |
| December 31, 2003 | 206.36M |
| December 31, 2002 | 73.98M |
| December 31, 2001 | 131.10M |
| December 31, 2000 | 40.20M |
| December 31, 1999 | 62.99M |
| December 31, 1998 | 11.39M |
| December 31, 1997 | 6.888M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ascendis Pharma A/S | 723.51M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Cytokinetics, Inc. | 885.34M |